Form4insider filings, from the source

SEC Form 4 · accession 0001179110-17-010285

BeOne Medicines Ltd. · ONC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John Oyler
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jul 6, 2017
Accepted (ET)
Jul 10, 2017 · 6:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
American Depositary SharesF1,F3Jul 6, 2017S7,345$60.6238D212,055D
American Depositary SharesF1,F4Jul 6, 2017S6,901$61.4954D205,154D
American Depositary SharesF1,F5Jul 6, 2017S10,324$62.5741D194,830D
American Depositary SharesF1,F6Jul 6, 2017S30,390$63.6318D164,440D
American Depositary SharesF1,F7Jul 6, 2017S44,695$64.5091D119,745D
American Depositary SharesF1,F8Jul 6, 2017S64,553$65.4174D55,192D
American Depositary SharesF1,F9Jul 6, 2017S51,821$66.3487D3,371D
American Depositary SharesF1,F10Jul 6, 2017S3,071$67.3608D300D
American Depositary SharesF1,F11Jul 6, 2017S300$68.11D0D
Ordinary Sharesholding———21,230,525D
Ordinary SharesF12holding———29,890,174ISee Footnote
Ordinary SharesF13holding———10,000,000ISee Footnote
Ordinary SharesF14holding———102,188ISee Footnote
Ordinary SharesF15holding———7,962,663ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses